WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model

Phuoc Vinh Nguyen; Katel Hervé-Aubert; Laurie Lajoie; Yoann Misericordia; Igor Chourpa; Stéphanie David; Emilie Allard-Vannier

doi:10.1016/j.ijpharm.2022.122335

WITHDRAWN: In vitro synergistic activity of cisplatin and EGFR-targeted nanomedicine of anti-Bcl-xL siRNA in a non-small lung cancer cell line model

Int J Pharm. 2023 Feb 5:632:122335. doi: 10.1016/j.ijpharm.2022.122335. Epub 2022 Oct 22.

Authors

Phuoc Vinh Nguyen¹, Katel Hervé-Aubert², Laurie Lajoie³, Yoann Misericordia², Igor Chourpa², Stéphanie David², Emilie Allard-Vannier⁴

Affiliations

¹ EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France; School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh City, Vietnam.
² EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France.
³ ISP UMR1282, INRAE, équipe BioMAP, Université de Tours, Tours, France.
⁴ EA6295 Nanomédicaments et Nanosondes, Université de Tours, Tours, France. Electronic address: emilie.allard@univ-tours.fr.

PMID: 36283640
DOI: 10.1016/j.ijpharm.2022.122335

Abstract

This article was withdrawn from International Journal of Pharmaceutics in order to be published in International Journal of Pharmaceutics: X. The Publisher apologizes for any inconvenience this may cause.

Publication types

Retraction of Publication